Post- Surgery Recovery: Nerve Blocks w/ Sedation vs. Nerve Block w/ Either Sedation/Gen. Anesthesia
NCT ID: NCT02602080
Last Updated: 2019-10-02
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
55 participants
OBSERVATIONAL
2015-12-31
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictive Factors for Postoperative Pain, Nausea and Vomiting in Oncological Patients
NCT04889534
Incidence and Factors Associated With PONV in Regional Anaesthesia
NCT03835234
Reduction of Postoperative Pain, Nausea and Vomiting
NCT01718132
Aromatherapy in Reducing PONV for Total Joint Replacement Patients
NCT07281885
Antiemetic Prophylaxis With Fosaprepitant and Ondansetron in Patients Undergoing Thoracic Surgery
NCT05881486
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
When peripheral nerve blocks have been applied for postoperative pain control, they significantly reduce postoperative pain, opioid consumption and side effects; patients receiving GA and nerve blocks are thought likely to have less nausea than patients receiving GA alone, due a reduction in pain leading to reduction in need for emetogenic opioids.
This study is a pilot study looking at the incidence and intensity of nausea after orthopedic surgery under nerve blocks in foot and ankle (FA) patients and under nerve blocks with either sedation or GA in total shoulder arthroplasty (TSA) patients. At the author's institution, TSA is commonly performed with a brachial plexus block and either GA or intravenous sedation. TSA patients represent a model system for the effect of GA on nausea among patients receiving nerve blocks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FA patients under popliteal block + spinal + sedation
Foot and ankle patients under popliteal block+ spinal+ sedation
No interventions assigned to this group
TSA patients under brachial plexus block + general (LMA)
Total shoulder arthroscopy patients under brachial plexus block + general (LMA)
No interventions assigned to this group
TSA patients under brachial plexus block + sedation
Total shoulder arthroplasty patients under brachial plexus block + sedation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-99
* Patients who are capable to provide informed consent and answer questions in English,
* For FA patients: Planned neuraxial anesthesia + nerve block for postsurgical analgesia,
* For TSA patients: Planned brachial plexus nerve block + either general anesthesia or IV sedation.
Exclusion Criteria
* Contraindications for regional or LMA anesthesia (anticoagulation, infection at injection site)
* Anticipated difficult airway
* Body mass index\>35
* Anticipated surgical procedure time less than 1 hour or more than 4 hours,
* History of severe postoperative nausea and/or vomiting
* American Society of Anesthesiologists physical status classification \>3
* Neuropathy
* Pregnant or nursing women
* Chronic opioid use (daily use of opioids one month prior to surgery/ patients requiring chronic pain interventions)
* Prone position planned for surgery
* Obstructive sleep apnea
* Known allergy/sensitivity to any study medications
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital for Special Surgery, New York
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jacques Ya Deau, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital for Special Surgery, New York
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital for Special Surgery, New York
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-397
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.